中国肺癌杂志Issue(6)：481-486,6.DOI:10.3779/j.issn.1009-3419.2014.06.08
非小细胞肺癌的驱动基因及其临床意义
Driver Genes and Its Clinical Signiifcance in Non-small Cell Lung Cancer
石岳泉 1杨向红2
作者信息
- 1. 110001沈阳，中国医科大学临床医学七年制
- 2. 110004沈阳，中国医科大学附属盛京医院病理科
- 折叠
摘要
Abstract
With the development of molecular biology technology and the transforming patterns of drug research, guiding molecular targeted therapy according to the drive gene mutation spectrum in lung cancer has gradually become a reality. Deifnition of the mutation incidence and whether existing advantage population groups in non-small cell lung cancer (NSCLC) have important guiding signiifcance in clinical practice. hTe purpose of this paper will draw a summary on the gen-eral characteristics, demographic features and clinical signiifcance of driver genes in NSCLC.关键词
肺肿瘤/驱动基因/临床意义Key words
Lung neoplasms/Driver gene/Clinical signiifcance引用本文复制引用
石岳泉,杨向红..非小细胞肺癌的驱动基因及其临床意义[J].中国肺癌杂志,2014,(6):481-486,6.
